SNIPETIDE Trademark of CHUGAI SEIYAKU KABUSHIKI KAISHA (Chugai Pharmaceutical Co., Ltd.) - Serial Number 98610157

SNIPETIDE Trademark

Trademark Overview

On Thursday, June 20, 2024, a trademark application was filed for SNIPETIDE with the United States Patent and Trademark Office. The USPTO has given the SNIPETIDE trademark a serial number of 98610157. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, June 20, 2024. This trademark is owned by CHUGAI SEIYAKU KABUSHIKI KAISHA (Chugai Pharmaceutical Co., Ltd.). The SNIPETIDE trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Contract manufacturing service in the field of pharmaceuticals; Contract manufacturing service in the field of compound synthesis; Contract manufacturing service in the field of peptide synthesis

Pharmaceutical preparations; Synthetic peptides for medical use; Chemical preparations for medical use

Testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; Clinical trials; Research and development in the field of biotechnology; pharmaceutical research into new drugs and development of drugs; Pharmaceutical and biological product development consultation relating to peptide; pharmaceutical and biological product development for others relating to peptide

General Information

Serial Number	98610157
Word Mark	SNIPETIDE
Filing Date	Thursday, June 20, 2024
Status	630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status Date	Thursday, June 20, 2024
Registration Number	0000000
Registration Date	NOT AVAILABLE
Mark Drawing	4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition Date	NOT AVAILABLE

Trademark Statements

Goods and Services	Contract manufacturing service in the field of pharmaceuticals; Contract manufacturing service in the field of compound synthesis; Contract manufacturing service in the field of peptide synthesis
Goods and Services	Pharmaceutical preparations; Synthetic peptides for medical use; Chemical preparations for medical use
Goods and Services	Testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; Clinical trials; Research and development in the field of biotechnology; pharmaceutical research into new drugs and development of drugs; Pharmaceutical and biological product development consultation relating to peptide; pharmaceutical and biological product development for others relating to peptide

Classification Information

International Class	005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes	005, 006, 018, 044, 046, 051, 052
Class Status Code	6 - Active
Class Status Date	Thursday, June 20, 2024
Primary Code	005
First Use Anywhere Date	NOT AVAILABLE
First Use In Commerce Date	NOT AVAILABLE

International Class	040 - Treatment of materials.
US Class Codes	100, 103, 106
Class Status Code	6 - Active
Class Status Date	Thursday, June 20, 2024
Primary Code	040
First Use Anywhere Date	NOT AVAILABLE
First Use In Commerce Date	NOT AVAILABLE

International Class	042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes	100, 101
Class Status Code	6 - Active
Class Status Date	Thursday, June 20, 2024
Primary Code	042
First Use Anywhere Date	NOT AVAILABLE
First Use In Commerce Date	NOT AVAILABLE

Trademark Owner History

Party Name	CHUGAI SEIYAKU KABUSHIKI KAISHA (Chugai Pharmaceutical Co., Ltd.)
Party Type	10 - Original Applicant
Legal Entity Type	03 - Corporation
Address	Tokyo 115-8543 JP

Trademark Events

Event Date	Event Description
Thursday, June 20, 2024	NEW APPLICATION ENTERED

Related Keywords

snipetide pharmaceutical field development peptide research service contract manufacturing product drugs